Boothbay Fund Management’s Neuronetics STIM Stock Holding History

Boothbay Fund Management’s Portfolio STIM Stock Details STIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$246K	Hold	189,263	–	–	﹤0.01%	1844
2026 Q1	$274K	Buy	189,263 +14,263	+8%	+$22.6K	﹤0.01%	1644
2025 Q4	$242K	Sell	175,000 -102,918	-37%	-$215K	﹤0.01%	1571
2025 Q3	$759K	Sell	277,918 -59,111	-18%	-$210K	0.01%	955
2025 Q2	$1.18M	Sell	337,029 -10,199	-3%	-$40.3K	0.02%	634
2025 Q1	$1.28M	Buy	+347,228	New	+$1.27M	0.03%	548
2024 Q3	–	Sell	-185,600	Closed	-$334K	–	1926
2024 Q2	$334K	Buy	185,600 +23,527	+15%	+$67.9K	0.01%	1125
2024 Q1	$771K	Buy	162,073 +143,689	+782%	+$505K	0.01%	847
2023 Q4	$53.3K	Buy	+18,384	New	+$29K	﹤0.01%	1516
2022 Q1	–	Sell	-29,764	Closed	-$133K	–	2513
2021 Q4	$133K	Buy	+29,764	New	+$146K	﹤0.01%	1649
2021 Q1	–	Sell	-13,000	Closed	-$144K	–	1774
2020 Q4	$144K	Buy	+13,000	New	+$97.7K	0.01%	1138

Other funds holding STIM

MAM

Madryn Asset Management New York $36.9M AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return

FCM

FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return

Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

MCM

Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Boothbay Fund Management's STIM Position: Q2 2026 in Review

Boothbay Fund Management held its Neuronetics (STIM) position steady in Q2 2026 at 189,263 shares worth $246K. The position accounts for ﹤0.01% of the portfolio, ranked #1844.

Boothbay Fund Management first reported a position in STIM in Q4 2020 and has held it in 11 quarters since. The position peaked at $1.28M in Q1 2025. 87 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

Boothbay Fund Management held 189,263 shares of Neuronetics worth $246K as of Q2 2026.
Boothbay Fund Management left its Neuronetics share count unchanged in Q2 2026.
Neuronetics made up ﹤0.01% of Boothbay Fund Management's portfolio in Q2 2026, its #1844 holding.
Boothbay Fund Management first reported a position in Neuronetics in Q4 2020 and has held it in 11 quarters since.
Boothbay Fund Management's Neuronetics position peaked at $1.28M in Q1 2025.
87 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.